Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
|
|
Other interstitial pulmonary diseases |
|
|
Autres affections pulmonaires interstitielles |
| Level | Code | Title | |
|---|---|---|---|
| 1 | X | Diseases of the respiratory system | |
| 2 | J80-J84 | Other respiratory diseases principally affecting the interstitium | |
| 3 | J84 | Other interstitial pulmonary diseases |
| Active Ingredient |
|---|
|
Nintedanib is a triple angiokinase inhibitor blocking vascular endothelial growth factor receptors (VEGFR 1-3), platelet-derived growth factor receptors (PDGFR α and β) and fibroblast growth factor receptors (FGFR 1-3) kinase activity. Nintedanib binds competitively to the adenosine triphosphate (ATP) binding pocket of these receptors and blocks the intracellular signalling which is crucial for the proliferation and survival of endothelial as well as perivascular cells (pericytes and vascular smooth muscle cells). |